Two Sigma Securities’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Two Sigma Securities’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,053	Closed	-$8.99K	–	2379
2024 Q4	$8.99K	Buy	+12,053	New	+$12K	﹤0.01%	1444

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Two Sigma Securities's OMGA Position: Q1 2025 in Review

Two Sigma Securities sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 12,053 shares — an estimated $8.99K sold.

Two Sigma Securities first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $8.99K in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Two Sigma Securities reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Two Sigma Securities sold 12,053 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $8.99K.
Two Sigma Securities first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Two Sigma Securities's Omega Therapeutics, Inc. Common Stock position peaked at $8.99K in Q4 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.